Insomnia has become a significant public health concern across the Asia-Pacific region, driven by rapid urbanization, increased work stress, shifting lifestyles, and rising awareness of mental health conditions.

Insomnia is characterized by difficulty falling asleep, staying asleep, or achieving restorative rest, leading to impaired daytime function and reduced quality of life. In major Asia-Pacific nations including Japan, China, India, South Korea, and Australia, long work hours, excessive screen exposure, and high academic or professional demands have contributed to a growing sleep-deprived population. Additionally, cultural stigma surrounding mental health often prevents individuals from seeking timely treatment, worsening chronic insomnia rates. The region has also seen an increase in age-related insomnia as populations age, along with sleep disturbances associated with anxiety, depression, cardiovascular disease, and metabolic disorders. Treatment approaches in Asia-Pacific are expanding beyond traditional sedatives and hypnotics to include cognitive behavioral therapy for insomnia (CBT-I), mindfulness-based therapy, lifestyle modification, melatonin supplements, herbal remedies, and digital sleep management platforms. Growing investment in sleep technology, wearable sleep trackers, and telemedicine services underscores the shift toward personalized sleep health. Governments and healthcare systems are also prioritizing sleep education as part of preventive medicine. As awareness rises and mental health infrastructures strengthen, Asia-Pacific is expected to witness increasing adoption of evidence-based insomnia therapies, improving sleep health outcomes across diverse populations.